Zobrazeno 1 - 10
of 146
pro vyhledávání: '"V. A. Polivanov"'
Autor:
A. R. Titova, N. V. Kosyakina, T. S. Polikarpova, Yu. S. Skorodumova, V. A. Polivanov, K. V. Gorelov
Publikováno v:
Безопасность и риск фармакотерапии, Vol 11, Iss 1, Pp 46-51 (2023)
A periodic benefit–risk evaluation report (PBRER) is a retrospective evaluation document enabling marketing authorisation holders to present the results of a critical analysis of the benefit–risk ratio of a medicinal product. PBRER submission and
Externí odkaz:
https://doaj.org/article/a05cd00c0c6540c6a68c6cc1f18366a7
Autor:
Marat R. Gismatulin
Publikováno v:
Археология евразийских степей, Iss 3, Pp 181-189 (2022)
The paper addresses the formation history of a collection of materials from the Muran burial ground of the Golden Horde period in the funds of the Ulyanovsk Regional Museum of Local Lore. The burial ground, located at Samara Luka, was first explored
Externí odkaz:
https://doaj.org/article/c2c9704d0c284e71aa9b9d849577f88c
Publikováno v:
Безопасность и риск фармакотерапии, Vol 10, Iss 4, Pp 381-395 (2022)
Serious adverse drug reactions (ADRs) to medicinal products can cause death. It is an immediate challenge for modern medicine to prevent the possibility of this outcome and to improve the safety of pharmacotherapy. The aim of this study was to identi
Externí odkaz:
https://doaj.org/article/d4d62f311e7848518c644ec2a81e8700
Autor:
N. Yu. Velts, E. O. Zhuravleva, G. V. Kutekhova, N. V. Tereshkina, A. O. Lovkova, K. V. Gorelov, V. A. Polivanov, S. M. Gyulakhmedova
Publikováno v:
Безопасность и риск фармакотерапии, Vol 10, Iss 3, Pp 259-268 (2022)
Adverse drug reactions (ADRs) are recorded throughout the lifecycle of a medicinal product. In the post-marketing period, new ADRs are primarily identified via drug safety signals. In order to assess a signal and establish causality between an advers
Externí odkaz:
https://doaj.org/article/d800373c951347cfb8c2c216c68f7e36
Publikováno v:
Безопасность и риск фармакотерапии, Vol 0, Iss 3, Pp 11-14 (2022)
The article presents recommendations for doctors, pharmacists, developers and manufacturers on how to prepare and report to the regulatory ofthe Russian Federation individual case safety reports of adverse drug reactions,unefficiency or adverse drug
Externí odkaz:
https://doaj.org/article/57869b4f00b34c0cb834148194223135
Autor:
E. O. Zhuravleva, V. A. Polivanov
Publikováno v:
Безопасность и риск фармакотерапии, Vol 0, Iss 2, Pp 31-39 (2022)
The article presents the retrospective analysis of reports on psychopharmaceuticals drugs safety to identify cases of off-label.
Externí odkaz:
https://doaj.org/article/c700b613c7864fefa9f7f2420fbaa3c0
Publikováno v:
Безопасность и риск фармакотерапии, Vol 9, Iss 3, Pp 144-153 (2021)
A well-known problem in pharmacotherapy is an increased risk of adverse drug reactions (ADRs) in older as compared to younger patients. The Russian pharmacovigilance database includes a significant number of spontaneous reports of suspected ADRs in p
Externí odkaz:
https://doaj.org/article/1bb32d0ec4aa4b96b01ee8c0f3cacfdb
Autor:
I. L. Asetskaya, S. K. Zyryanov, K. I. Samsonova, O. I. Butranova, E. N. Terekhina, V. A. Polivanov
Publikováno v:
Безопасность и риск фармакотерапии, Vol 0, Iss 0 (2022)
INTRODUCTION. Newly identified risks associated with the use of fluoroquinolones and the spread of antimicrobial resistance make the identification and analysis of medication errors (MEs) in prescribing fluoroquinolones especially important for provi
Externí odkaz:
https://doaj.org/article/8c93de3b40044e28836e472cefd49fdc
Publikováno v:
Антибиотики и Химиотерапия, Vol 64, Iss 11-12, Pp 48-53 (2020)
The authors conducted a retrospective analysis of Russian database of spontaneous reports (SRs) for the period from 01.01.2012 to 01.08.2014. They analyzed 3608 SRs concerning adverse drug reactions associated with beta-lactam antibiotics to identify
Externí odkaz:
https://doaj.org/article/6cc58f3ee1804276a5b00b716e77a682
Autor:
A. V. Philippova, A. S. Kolbin, E. V. Verbitskaya, S. V. Glagolev, V. A. Polivanov, V. I. Mazurov, R. R. Samigullina
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 3, Pp 44-52 (2020)
Success in practical rheumatology of the latest decade achieved mainly due to monoclonal antibodies (MABs) appearance in routine medical practice. At the same time, the experience of practical application of MABs is limited both by observation period
Externí odkaz:
https://doaj.org/article/72820a4596e84a109fabdd2977836ad6